ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Inflammation Disrupts Memory - What Can You Do to Protect Your Brain?

Artificial sweeteners linked to risk of weight gain, heart disease and other health issues

All About Ginkgo Biloba: Benefits of This Timeless Herbal Supplement

Yarrow Oil: Here's Why It Deserves a Place in Your First-Aid Kit

Vitamin D supplement use associated with lower risk of breast cancer

Carnitine deficiency suggested as contributor to autism

Hop Oil: A Safe Sleep Aide

Lutein — An Important Nutrient for Eye and Brain Health

White Camphor Oil: The Purest Camphor Oil

Taurine: Facts About This Crucial Amino Acid

 
Print Page
Email Article

Stanford Researchers Shine Light on New Genes Involved in Multiple Sclerosis

  [ 15 votes ]   [ Discuss This Article ]
www.ProHealth.com • April 30, 2002





STANFORD, Calif. - Using microarray technology, researchers at Stanford University Medical Center have uncovered thousands of genes that may be involved in multiple sclerosis. Although some of the genes are new, others were known genes that had previously been thought to play roles that were unrelated to MS. These results could lead to new treatments and help clarify previous observations about the disease.

"We've been bumping around looking at a few genes," said Lawrence Steinman, MD, professor of neurology and neurological sciences. "Now there are hundreds if not thousands of other genes that may be critical." This work will be published in the May issue of Nature Medicine.

MS occurs when cells of the immune system target their attack on cells that insulate neurons in the brain. The disease generally progresses in stages with an acute attack followed by a recovery - or chronic phase - in which the insulating cells degenerate and scar tissue builds up. Eventually, the disease can lead to paralysis and sensory disturbances such as blindness or deafness.

Steinman looked at which genes were being expressed in both acute and chronic attacks and compared them with the genes active in normal brain tissue.

To do this, Steinman's team isolated messenger RNA from acute, chronic and normal brain samples (mRNA is produced by active genes and can be used to identify which genes are being expressed in a given sample). They then exposed the mRNA samples to a gene chip - a glass slide dotted with human genes. If a sample contained mRNA corresponding to a gene on the chip, it would bind to the spot and produce a visible signal. The bigger the signal, the more mRNA, and therefore the more actively the gene is expressed in the sample.

With this technique, Steinman picked out thousands of genes that were expressed at either higher or lower levels in MS compared to the normal brain sample. Some of these genes were exactly what Steinman would have predicted, including the immune-stimulating factors called cytokines. "We would expect to see angry, inflammatory cytokines in acute MS and scarring in chronic MS, and indeed that's what we did find," he said.

But he also had some surprises. Steinman found genes expressed at high levels that had previously been found only in bones, in allergic responses and in pregnancy. He said that with only 30,000 genes to work with, the body may reuse genes for many roles. "Multiple purposes may be the rule," he said. He expects that future gene-chip experiments will turn up additional known genes playing previously unknown roles.

Some of the unexpected proteins Steinman found may help resolve previous observations about MS treatment. In the past, people have found that both pregnancy and allergy can prevent MS, he said, but nobody understood why. Among the genes that were overexpressed was a histamine receptor and proteins associated with pregnancy. These results could lead to the regular use of antihistamines to treat MS. "It sure is easier to start with a drug that's approved for over-the-counter use," Steinman said.

He also intends to test novel proteins for use in preventing MS. To verify that proteins found in this study could lead to possible cures, Steinman tested two treatments in a mouse model. In one, he created a mouse line that was prone to developing MS but lacked a gene that was overexpressed in chronic MS. These mice had fewer signs of the disease during the chronic phase than the MS-prone mice that still had the overexpressed gene. He also injected MS-prone mice with a protein found in the acute phase of the disease and saw a delay in the onset of MS in the mice.

The complete list of genes that are overexpressed or underexpressed in acute and chronic MS will be published online in conjunction with the paper. Steinman hopes other researchers will scrutinize this list and devise their own novel treatment strategies. "There will be a lot of people who might mine this data for real nuggets," he said.


Primary authors on the paper include Stanford postdoctoral researchers Christopher Lock, MD, PhD; Guy Hermans, PhD; Rosetta Pedotti, MD; and Andrea Brendolan, MD. The research was done in full collaboration with Renu Heller, PhD, at Roche Biosciences, who was instrumental in developing microarrays for analyzing tissue from human diseases.

Stanford University Medical Center integrates research, medical education and patient care at its three institutions - Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children's Hospital. For more information, please visit the Web site of the medical center's Office of Communication & Public Affairs at http://mednews.stanford.edu.



Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Ultra EPA  - Fish Oil Vitamin D3 Extreme™


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Strontium - The Missing Mineral for Strong Bones Strontium - The Missing Mineral for Strong Bones
Health Benefits Are Brewing in Green Tea Health Benefits Are Brewing in Green Tea
Coconut Oil - Healthy Gifts from the 'Tree of Life' Coconut Oil - Healthy Gifts from the 'Tree of Life'
Natural Relief for Soreness, Pain and Swelling - Putting Out the Fire Natural Relief for Soreness, Pain and Swelling - Putting Out the Fire
Relief for Dry, Itchy Skin Caused by Fibromyalgia Relief for Dry, Itchy Skin Caused by Fibromyalgia

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map